Premium
Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial
Author(s) -
RODGER M. A.,
KAHN S. R.,
CRANNEY A.,
HODSMAN A.,
KOVACS M. J.,
CLEMENT A. M.,
LAZOLANGNER A.,
HAGUE W. M.
Publication year - 2007
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2007.02634.x
Subject(s) - randomized controlled trial , bone mineral , medicine , term (time) , pregnancy , obstetrics , osteoporosis , biology , genetics , physics , quantum mechanics
The risk of decreased bone mineral density (BMD) with prophylactic dose long-term low-molecular-weight heparin (LMWH) is unknown.